Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Vivos Therapeutics, Inc. VVOS
$0.34
+$0.01 (1.68%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
10671215.00000000
-
week52high
2.96
-
week52low
0.30
-
Revenue
16024000
-
P/E TTM
0
-
Beta
2.61989600
-
EPS
-0.96000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 10:59
Описание компании
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Roth Capital | Buy | Buy | 13 авг 2021 г. |
| Roth Capital | Buy | Buy | 18 мая 2021 г. |
| Craig-Hallum | Buy | 11 янв 2021 г. | |
| Roth Capital | Buy | 05 янв 2021 г. | |
| Ascendiant Capital | Buy | 17 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Green Ralph Elias | A | 76667 | 30000 | 23 дек 2022 г. |
| Thompson Matthew | A | 76667 | 30000 | 23 дек 2022 г. |
| Amman Bradford K. | A | 500001 | 200000 | 23 дек 2022 г. |
| Huntsman Ronald Kirk | A | 483334 | 150000 | 23 дек 2022 г. |
| Huntsman Ronald Kirk | A | 333334 | 333334 | 23 дек 2022 г. |
| Huntsman Ronald Kirk | A | 47500 | 20000 | 23 дек 2022 г. |
| Lindsay Mark F. | A | 76667 | 30000 | 23 дек 2022 г. |
| Krammer Anja B | A | 76667 | 30000 | 23 дек 2022 г. |
| SOKOLOW LEONARD J | A | 76667 | 30000 | 23 дек 2022 г. |
| Huntsman Ronald Kirk | A | 27500 | 4000 | 01 июн 2022 г. |
Новостная лента
What Makes Penny Stocks Move? 3 Major Factors to Consider
PennyStocks
05 янв 2023 г. в 06:00
Here's why penny stocks climb in price The post What Makes Penny Stocks Move? 3 Major Factors to Consider appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The Sleep Apnea News That Has VVOS Stock Soaring Today
InvestorPlace
04 янв 2023 г. в 12:57
Vivos Therapeutics (NASDAQ: VVOS ) stock is rocketing higher on Wednesday as investors react to positive news from the U.S. Food and Drug Administration (FDA). The FDA has approved Vivos Therapeutics' proprietary DNA appliance.
7 Top Penny Stocks To Watch With Big News This Week
PennyStocks
04 янв 2023 г. в 09:14
Hot penny stocks to watch with news this week. The post 7 Top Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Vivos Therapeutics, Inc. (VVOS) Q2 and Q3 2022 Earnings Call Transcript
Seeking Alpha
20 дек 2022 г. в 22:25
Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q2 and Q3 2022 Earnings Conference Call December 20, 2022 5:00 PM ET Company Participants Julie Gannon - Chief of Staff and Investor Relations Kirk Huntsman - Chairman and Chief Executive Officer Brad Amman - Chief Financial Officer Conference Call Participants Scott Henry - ROTH Capital Alexander Nowak - Craig-Hallum Capital Group Operator Good day, everyone and welcome to the Vivos Therapeutics Second and Third Quarter 2022 Earnings Conference Call. At this time participants are in a listen-only mode.
Vivos Therapeutics Schedules Release of Second and Third Quarter 2022 Financial Results and Conference Call
GlobeNewsWire
16 дек 2022 г. в 07:30
Call Scheduled for Tuesday, December 20, 2022 at 5:00 pm ET Call Scheduled for Tuesday, December 20, 2022 at 5:00 pm ET